Business · 19/11/2010Updated: 10/17/2026 · 1 min read
FDA Announces Upcoming Meeting of Cardiovascular and Renal Drugs Advisory Committee
Summary
The US Food and Drug Administration (FDA) has scheduled a meeting of the Cardiovascular and Renal Drugs Advisory Committee to discuss various cardiovascular and renal drug proposals, with the meeting set to take place in the near future.
Original source language: Federal Register — Health and Human ServicesOpen original release →